For that reason, they say the next step should be a study where some people with the mutated gene are given aspirin and others are not, so their cancer outcomes can be compared more directly.
One colon cancer patient, L. Stewart Keefe, 60, a retired interior decorator and painter from Alton, N.H., decided several years ago to try it.
"I figured, what have I got to lose by taking some aspirin? It just seems like it was a simple enough thing to take," she said. "For me the bleeding risk is a very small possible consequence" compared with the risk of cancer coming back, she said.
Medical journal: http://www.nejm.org
Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.